113 related articles for article (PubMed ID: 16157976)
1. Serum hemoglobin level determined at the first presentation is a poor prognostic indicator in patients with lung cancer.
Aoe K; Hiraki A; Maeda T; Katayama H; Fujiwara K; Tabata M; Kiura K; Ueoka H; Tanimoto M
Intern Med; 2005 Aug; 44(8):800-4. PubMed ID: 16157976
[TBL] [Abstract][Full Text] [Related]
2. Thrombocytosis as a useful prognostic indicator in patients with lung cancer.
Aoe K; Hiraki A; Ueoka H; Kiura K; Tabata M; Tanaka M; Tanimoto M
Respiration; 2004; 71(2):170-3. PubMed ID: 15031573
[TBL] [Abstract][Full Text] [Related]
3. Does anemia affect outcome after lobectomy or pneumonectomy in early stage lung cancer patients who have not received neo-adjuvant treatment?
Chamogeorgakis T; Anagnostopoulos C; Kostopanagiotou G; Bhora F; Toumpoulis I; Georgiannakis E; Nabong A; Dosios T; Harrison L; Connery C
Thorac Cardiovasc Surg; 2008 Apr; 56(3):148-53. PubMed ID: 18365973
[TBL] [Abstract][Full Text] [Related]
4. [Impact of anemia on chemotherapy efficacy and prognosis in patients with advanced non-small cell lung cancer].
Xu C; Gao Y; Li L; Xing L; Liu S
Zhongguo Fei Ai Za Zhi; 2010 Oct; 13(10):968-74. PubMed ID: 20959070
[TBL] [Abstract][Full Text] [Related]
5. [Impact of hemoglobin level on lung cancer survival].
García Prim JM; González Barcala FJ; Moldes Rodríguez M; Alvarez Dobañob JM; Hervada Vidal X; Pose Reino A; Valdés Cuadrado L
Med Clin (Barc); 2008 Nov; 131(16):601-4. PubMed ID: 19080849
[TBL] [Abstract][Full Text] [Related]
6. The importance of pre-treatment haemoglobin level in inoperable non-small cell lung carcinoma treated with radical radiotherapy.
Langendijk H; de Jong J; Wanders R; Lambin P; Slotman B
Radiother Oncol; 2003 Jun; 67(3):321-5. PubMed ID: 12865181
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancer.
Ni XF; Wu P; Wu CP; Ji M; Wu J; Gu XF; Jiang ZX
Asia Pac J Clin Oncol; 2015 Dec; 11(4):e22-30. PubMed ID: 24889374
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between anemia and clinical features and prognosis of advanced lung cancer patients].
Wang L; Shao ZH
Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):512-516. PubMed ID: 30060359
[No Abstract] [Full Text] [Related]
9. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer.
Milman N; Pedersen LM
Oncol Rep; 2002; 9(1):193-8. PubMed ID: 11748482
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment Anemia Portends Poor Survival and Nonlocal Disease Progression in Patients with Stage I Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy.
Shaverdian N; Veruttipong D; Wang J; Kupelian P; Steinberg M; Lee P
J Thorac Oncol; 2016 Aug; 11(8):1319-1325. PubMed ID: 27234604
[TBL] [Abstract][Full Text] [Related]
11. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of the serum crosslinked N-telopeptide of type I collagen as a prognostic marker for non-small-cell lung cancer.
Tamiya M; Kobayashi M; Morimura O; Yasue T; Nakasuji T; Satomu M; Kohei O; Takayuki S; Morishita N; Suzuki H; Sasada S; Okamoto N; Hirashima T; Kawase I
Clin Lung Cancer; 2013 Jan; 14(1):50-4. PubMed ID: 22609050
[TBL] [Abstract][Full Text] [Related]
13. A laboratory prognostic index model for patients with advanced non-small cell lung cancer.
Ulas A; Turkoz FP; Silay K; Tokluoglu S; Avci N; Oksuzoglu B; Alkis N
PLoS One; 2014; 9(12):e114471. PubMed ID: 25474743
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors affecting survival in non-small cell lung carcinoma patients with malignant pleural effusions.
Kasapoglu US; Arınç S; Gungor S; Irmak I; Guney P; Aksoy F; Bandak D; Hazar A
Clin Respir J; 2016 Nov; 10(6):791-799. PubMed ID: 25764010
[TBL] [Abstract][Full Text] [Related]
15. Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer.
Joensuu H; Anttonen A; Eriksson M; Mäkitaro R; Alfthan H; Kinnula V; Leppä S
Cancer Res; 2002 Sep; 62(18):5210-7. PubMed ID: 12234986
[TBL] [Abstract][Full Text] [Related]
16. Important prognostic factors for survival in patients with malignant pleural effusion.
Zamboni MM; da Silva CT; Baretta R; Cunha ET; Cardoso GP
BMC Pulm Med; 2015 Mar; 15():29. PubMed ID: 25887349
[TBL] [Abstract][Full Text] [Related]
17. Impact of preoperative hemoglobin level on survival of non-small cell lung cancer patients.
Tomita M; Shimizu T; Hara M; Ayabe T; Onitsuka T
Anticancer Res; 2008; 28(3B):1947-50. PubMed ID: 18630486
[TBL] [Abstract][Full Text] [Related]
18. Hypercalcemia-leukocytosis syndrome associated with lung cancer.
Hiraki A; Ueoka H; Takata I; Gemba K; Bessho A; Segawa Y; Kiura K; Eguchi K; Yoneda T; Tanimoto M; Harada M
Lung Cancer; 2004 Mar; 43(3):301-7. PubMed ID: 15165088
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic factors in unresectable lung cancer].
Urata A
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2035-42. PubMed ID: 2840034
[TBL] [Abstract][Full Text] [Related]
20. The relationship of pretreatment serum hemoglobin level to the survival of epithelial ovarian carcinoma patients: a prospective review.
Obermair A; Handisurya A; Kaider A; Sevelda P; Kölbl H; Gitsch G
Cancer; 1998 Aug; 83(4):726-31. PubMed ID: 9708937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
